Asthma
75 drugs228,410 FAERS reportsMedDRA PT
GET
/api/v1/reaction/asthmaReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D001249
A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
Drugs reporting Asthma (75)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Edetate3073%
- 2Edetate Calcium3073%
- 3Ciclesonide5,80944%
- 4Helicobacter Pylori2743%
- 5Epidermal Growth Factor240%
- 6Racepinephrine1537%
- 7Depemokimab633%
- 8Acetylcholine3329%
- 9Mepolizumab12,63526%
- 10Ropivacaine49722%
- 11Terbutaline37121%
- 12Aminophylline38120%
- 13Theophylline2,03517%
- 14Benralizumab2,88015%
- 15Tezepelumab86515%
- 16Omalizumab11,89314%
- 17Reslizumab9214%
- 18Aclidinium81613%
- 19Cefadroxil23412%
- 20Zileuton7612%
- 21Pyrilamine4912%
- 22Formoterol14,11111%
- 23Montelukast18,47911%
- 24Ipratropium4,14111%
- 25Zafirlukast9211%
- 26Moxifloxacin1,98810%
- 27Salmeterol10,81310%
- 28Carbachol138.5%
- 29Albuterol24,4928.4%
- 30Tiotropium12,2328.1%
- 31Efinaconazole1548.1%
- 32Acebutolol917.3%
- 33Beclomethasone6696.8%
- 34Fluticasone17,7726.7%
- 35Malic Acid16.7%
- 36Risedronate1,9546.4%
- 37Nortriptyline3566.3%
- 38Propionate12,6626.3%
- 39Vilanterol5,5756.3%
- 40Mometasone4,0616.2%
- 41Levalbuterol4026.1%
- 42Glyphosate15.9%
- 43Penicillin V1445.9%
- 44Methacholine45.6%
- 45Acetaldehyde15.6%
- 46Ketoprofen6014.7%
- 47Glucagon1914.7%
- 48Cefprozil344.4%
- 49Tramadol1,6404.4%
- 50Roflumilast2894.3%
- 51Standardized Senna Concentrate5774.2%
- 52Liothyronine3544.1%
- 53Polymyxin B1944.0%
- 54Potassium Gluconate14.0%
- 55Pralidoxime13.8%
- 56Azelastine8173.8%
- 57Umeclidinium2,4073.8%
- 58Bepotastine243.8%
- 59Meclofenamate23.7%
- 60Azithromycin2,1193.6%
- 61Tavaborole23.6%
- 62Prednisone17,4963.6%
- 63Dupilumab14,7153.4%
- 64Nefazodone43.3%
- 65Diethylpropion43.2%
- 66Progesterone6963.1%
- 67Fumarate16,3063.1%
- 68Formate23.0%
- 69Cromolyn1002.9%
- 70Acetylcysteine2602.9%
- 71Ephedrine162.5%
- 72Dutasteride4612.1%
- 73Articaine151.9%
- 74Oxymorphone950.8%
- 75Beta Carotene3—
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Wheezing36 shared · 0.40
- Chronic Obstructive Pulmonary Disease15 shared · 0.17
- Productive Cough13 shared · 0.15
- Therapeutic Product Effect Incomplete15 shared · 0.12
- Chest Discomfort17 shared · 0.12
- Obstructive Airways Disorder8 shared · 0.10
- Cough48 shared · 0.10
- Sinusitis10 shared · 0.09
- Loss Of Personal Independence In Daily Activities7 shared · 0.08
- Drug Hypersensitivity20 shared · 0.08
Literature
Recent PubMed references pinned to Asthma as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Histone Lactylation Enhances Th17 Cell Differentiation Through DPP4 to Promote Epithelial-Mesenchymal Transition in Asthma.Lung · 2026 · Zhong X, Luo Y, Su J, et al.PMID 42204013DOI 10.1007/s00408-026-00894-y
- Validating exacerbations of asthma in electronic health records: a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2026 · Moore E, Gassasse Z, Sinha I, et al.PMID 42203235DOI 10.1183/16000617.0004-2026
- Current understanding and future directions in severe asthma through artificial intelligence-integrated multi-omic approaches.European respiratory review : an official journal of the European Respiratory Society · 2026 · Valappil SR, Uddin M, Al Heialy S, et al.PMID 42203233DOI 10.1183/16000617.0040-2025
- The evolution of scientific knowledge in childhood asthma over time.European respiratory review : an official journal of the European Respiratory Society · 2026 · Ferrante G, Tenero L, Zaffanello M, et al.PMID 42203231DOI 10.1183/16000617.0256-2025
- Association Between Air Pollution and Childhood Asthma: A Systematic Review of Recent Evidence.Advances in respiratory medicine · 2026 · Kyrmanidou M, Smaraidos I, Kampouras A, et al.PMID 42201234DOI 10.3390/arm94030031
- Chronic Obstructive Pulmonary Disease and Asthma Among Workers and Residents of Navanakorn Industrial Zone, Thailand.Medical sciences (Basel, Switzerland) · 2026 · Saiphoklang N, Ruchiwit P, Vatcharavongvan P, et al.PMID 42200999DOI 10.3390/medsci14020208
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.